Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Ekblad, Lars ^a   Lindgren, Gustaf ^a   Persson, Emma ^b   Kjellén, Elisabeth ^a   Wennerberg, Johan ^a  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Head and neck cancer; IL 6; IL6R; Invasion; Local recurrence; Migration; Proliferation; STAT3; Tocilizumab; Wound healing

Indexed keywords

BIOLOGICAL FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 6 RECEPTOR; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; UNCLASSIFIED DRUG; WOUND HEALING FACTOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SCATTERING; CELL SPECIFICITY; CELL STIMULATION; CELLULAR PARAMETERS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; INTRACELLULAR SIGNALING; PHENOTYPE; PROTEIN FUNCTION; PROTEIN INDUCTION; RECURRENT CANCER; THYROIDECTOMY; WESTERN BLOTTING; WOUND FLUID; WOUND HEALING;

BIOLOGICAL FACTORS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR FLUID; EXUDATES AND TRANSUDATES; HEAD AND NECK NEOPLASMS; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; ONCOGENE PROTEIN V-AKT; STAT3 TRANSCRIPTION FACTOR; WOUND HEALING;

EID: 84872760879     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-33     Document Type: Article

References (37)

1. Globocan 2008 http://globocan.iarc.fr/.
2. Braakhuis BJ, Bloemena E, Leemans CR, Brakenhoff RH. Molecular analysis of surgical margins in head and neck cancer: More than a marginal issue. Oral Oncol 2010, 46(7):485-491. 10.1016/j.oraloncology.2010.01.019, 20189442.
3. Curet MJ. Port site metastases. Am J Surg 2004, 187:705-712. 10.1016/j.amjsurg.2003.10.015, 15191862.
4. Lundberg O, Kristoffersson A. Wound recurrence from gallbladder cancer after open cholecystectomy. Surgery 2000, 127(3):296-300. 10.1067/msy.2000.104487, 10715985.
5. Abramovitch R, Marikovsky M, Meir G, Neeman M. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 1999, 79(9/10):1392-1398. 10.1038/sj.bjc.6690223, 2362730, 10188881.
6. Baker DG, Masterson TM, Pace R, Constable WC, Wanebo H. The influence of the surgical wound on local tumor recurrence. Surgery 1989, 106(3):525-532.
7. Bogden AE, Moreau JP, Eden PA. Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 1997, 75(7):1021-1027. 10.1038/bjc.1997.175, 2222742, 9083338.
8. Hofer SOP, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-Induced Tumor Progression: A Probable Role in Recurrence After Tumor Resection. Arch Surg 1998, 133(4):383-389. 10.1001/archsurg.133.4.383, 9565118.
9. Lee JY, Murphy SM, Scanlon EF. Effect of trauma on implantation of metastatic tumor in bone in mice. J Surg Oncol 1994, 56(3):178-184. 10.1002/jso.2930560311, 8028350.
10. Murthy SM, Goldschmidt RA, Rao LN, Ammirati M, Buchmann T, Scanlon EF. The influence of surgical trauma on experimental metastasis. Cancer 1989, 64(10):2035-2044-2044.
11. Rho O, Kim DJ, Kiguchi K, Digiovanni J. Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog 2011, 50(4):264-279. 10.1002/mc.20665, 3005141, 20648549.
12. Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, Martel M, Giovanazzi R, Greco M, Balsari A, et al. Role of HER2 in wound-induced breast carcinoma proliferation. Lancet 2003, 362(9383):527-533. 10.1016/S0140-6736(03)14112-8, 12932384.
13. Licitra L, Perrone F, Tamborini E, Bertola L, Ghirelli C, Negri T, Orsenigo M, Filipazzi P, Pastore E, Pompilio M, et al. Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients. Ann Oncol 2011, 22(8):1886-1893. 10.1093/annonc/mdq756, 21343382.
14. Roh J-L, Sung M-W, Kim KH. Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin. Head Neck 2005, 27(4):326-332. 10.1002/hed.20167, 15719392.
15. Cohen HJ, Laszlo J. Influence of trauma on the unusual distribution of metastases from carcinoma of the larynx. Cancer 1972, 29(2):466-471. 10.1002/1097-0142(197202)29:2<466::AID-CNCR2820290234>3.0.CO;2-M, 5013548.
16. Walter ND, Rice PL, Redente EF, Kauvar EF, Lemond L, Aly T, Wanebo K, Chan ED. Wound healing after trauma may predispose to lung cancer metastasis: review of potential mechanisms. Am J Respir Cell Mol Biol 2011, 44(5):591-596. 10.1165/rcmb.2010-0187RT, 21177982.
17. Henriksson E, Baldetorp B, Borg T, Kjellén E, Åkervall J, Wennerberg J, Wahlberg P. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck. Acta Oncol 2006, 45(3):300-305. 10.1080/02841860600547380, 16644573.
18. Henriksson E, Kjellén E, Baldetorp B, Bendahl PO, Borg T, Brun E, Mertens F, Ohlsson T, Rennstam K, Wennerberg J, et al. Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck. J Exp Clin Cancer Res 2009, 28:17. 10.1186/1756-9966-28-17, 2654548, 19216775.
19. Oshima G, Wennerberg J, Yamatodani T, Kjellen E, Mineta H, Johnsson A, Ekblad L. Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines. J Cancer Res Clin Oncol 2012, 138(3):491-499. 10.1007/s00432-011-1127-5, 22193422.
20. Helsinki Declaration http://www.wma.net/en/30publications/10policies/b3/index.html, Helsinki Declaration.
21. Yamatodani T, Ekblad L, Kjellén E, Johnsson A, Mineta H, Wennerberg J. Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines. J Cancer Res Clin Oncol 2009, 135(3):395-402. 10.1007/s00432-008-0475-2, 18813952.
22. Welinder C, Ekblad L. Coomassie staining as loading control in Western blot analysis. J Proteome Res 2011, 10(3):1416-1419. 10.1021/pr1011476, 21186791.
23. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009, 119(6):1429-1437. 10.1172/JCI36183, 2689132, 19487819.
24. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003, 4(12):915-925. 10.1038/nrm1261, 14685170.
25. Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 1998, 391(6664):285-288. 10.1038/34657, 9440692.
26. Zhang YW, Wang LM, Jove R, Vande Woude GF. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Oncogene 2002, 21(2):217-226. 10.1038/sj.onc.1205004, 11803465.
27. Roh JL, Sung MW, Kim KH. Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin. Head Neck 2005, 27(4):326-332. 10.1002/hed.20167, 15719392.
28. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2(6):442-454. 10.1038/nrc822, 12189386.
29. Holstein SA, Hohl RJ. Therapeutic additions and possible deletions in oncology in 2011. Clin Pharmacol Ther 2012, 91(1):15-17. 10.1038/clpt.2011.288, 22179625.
30. Werner S, Grose R. Regulation of Wound Healing by Growth Factors and Cytokines. Physiol Rev 2003, 83(3):835-870.
31. Conway K, Price P, Harding KG, Jiang WG. The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Repair Regen 2006, 14(1):2-10. 10.1111/j.1524-475X.2005.00081.x, 16476066.
32. Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005, 41(16):2502-2512. 10.1016/j.ejca.2005.08.016, 16199153.
33. Chakravarti N, Myers JN, Aggarwal BB. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 2006, 119(6):1268-1275. 10.1002/ijc.21967, 16642480.
34. Pries R, Thiel A, Brocks C, Wollenberg B. Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma. In Vivo 2006, 20(1):45-48.
35. Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 2008, 113(4):750-757. 10.1002/cncr.23615, 18536030.
36. Kermorgant S, Parker PJ. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J Cell Biol 2008, 182(5):855-863. 10.1083/jcb.200806076, 2528569, 18779368.
37. McShane MP, Zerial M. Survival of the weakest: signaling aided by endosomes. J Cell Biol 2008, 182(5):823-825. 10.1083/jcb.200807165, 2528579, 18779366.